Feature selection strongly affected radiomics prediction of xerostomia after head-and-neck RT

T1 MRI with R-MRmr reached AUC 0.96 for early xerostomia, while late sticky-saliva prediction remained substantially weaker.

KEY POINTS

  • The multicentre cohort included 250 head-and-neck cancer patients from three institutions. Centers 1 and 2 contributed 178 patients for model development, while 72 patients from Center 3 were completely withheld for independent institutional testing.
  • The models combined 321 radiomic features from CT, T1-weighted MRI and T2-weighted MRI with 20 clinical and dosimetric variables. Nine feature-reduction strategies and five machine-learning classifiers were evaluated.
  • Toxicity was patient reported using EORTC QLQ-H&N35. Moderate-to-severe early xerostomia occurred in 71%, late xerostomia in 44%, early sticky saliva in 55% and late sticky saliva in 16%.
  • Feature-selection strategy had a large effect on discrimination. For early xerostomia, R-MRmr with T1 MRI achieved AUC 0.96, with accuracy 0.90, sensitivity 0.87 and specificity 0.93 in the independent-center evaluation.
  • Early sticky saliva was also predicted best using R-MRmr with T1 MRI, reaching AUC 0.85. Relief performed best for late xerostomia, with AUC 0.88 using T1 MRI.
  • Late sticky saliva was considerably harder to predict. The best configuration, Relief using combined CT, T1 and T2 MRI, achieved only AUC 0.65, despite class-balancing methods.
  • More imaging was not necessarily better. T1-weighted MRI repeatedly outperformed CT and T2 MRI, while combining CT + T1 + T2 did not consistently improve prediction, potentially because the larger feature space increased redundancy and model complexity.
  • External testing was limited to a single 72-patient institution, calibration and clinical net benefit were not assessed, feature stability was not formally quantified and numerous exploratory comparisons were performed without multiplicity correction.

CLINICAL TAKEAWAY

For radiomics toxicity models, the feature-selection pipeline may matter almost as much as the imaging itself. T1 MRI showed promising prediction of xerostomia across an independent institution, but these models still need multicentre validation, calibration and decision-curve analysis before they can inform individual RT planning.

SOURCE

Cancers

Browse more research Suggest a correction